Role of mast cells in gastrointestinal mucosal defense

Biocell

Volumn 27, Issue 2, 2003, Pages 163-172

  Penissi, Alicia B ^a   Rudolph, María I ^b   Piezzi, Ramón S ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Dehydroleucodine; Gastrointestinal; Mast cells; Mucosal defense

Indexed keywords

5 (2 HYDROXYPROPOXY) 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; ALOE VERA EXTRACT; CHONDROITIN SULFATE; CROMOGLYCATE DISODIUM; DEHYDROLEUCODINE; FLAVONOID; HISTAMINE; KETOTIFEN; QUERCETIN; SEROTONIN; SESQUITERPENE LACTONE; UNCLASSIFIED DRUG; ZINC DERIVATIVE;

ARTEMISIA; BACTERIAL INFECTION; CELL PROTECTION; DRUG STRUCTURE; FOOD ALLERGY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MUCOSA; HISTAMINE RELEASE; HOST RESISTANCE; HUMAN; IMMUNOBIOLOGY; MAST CELL; NONHUMAN; PARASITOSIS; REVIEW; SEROTONIN RELEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DIGESTIVE SYSTEM; GASTRIC MUCOSA; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LACTONES; MAST CELLS; SESQUITERPENES;

ALOE; ALOE VERA; ARTEMISIA; ARTEMISIA DOUGLASIANA; BACTERIA (MICROORGANISMS);

EID: 0043192553     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Andoh A, Fujiyama Y, Araki Y, Kim Lira T, Tsujikawa T, Bamba T (2001). Role of complement activation and mast cell degranulation in the pathogenesis of rapid intestinal ischemia/reperfusion injury in rats. Digestion. 63: 103-107.
2. Ares JJ, Outt PE (1998). Gastroprotective agents for the prevention of NSAID-induced gastropathy. Curr Pharm Des. 4: 17-36.
3. Armetti L, Admon D, Solomon A, Levi-Schaffer F (1999). Mast cells and eosinophils-Their role in tissue remodeling. ACI International. 11: 22-28.
4. Arnold JW, Klimpel GR, Niesel DW (1993). Tumour necrosis factor (TNF alpha) regulates intestinal mucus production during salmonellosis. Cell Immunol. 151: 336-344.
5. Barczyk M, Debek W, Chyczewski L (1995). Mast cells in the gastrointestinal tract. Rocz Akad Med Bialymst. 40: 26-57.
6. Bischoff SC, Mayer JH, Manns MP (2000). Allergy and the gut. Int Arch Allergy Immunol. 121: 270-283.
7. Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, Maschek H, Stolte M, Gebel M, Manns MP (1996). Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 28: 1-13.
8. Boros M, Kaszaki J, Ordogh B, Nagy S (1999a). Mast cell degranulation prior to ischemia-reperfusion injury in the canine small intestine. Inflamm Res. 48: 193-198.
9. Boros M, Ordogh B, Kaszaki J, Nagy S (1999b). The role of mast cell degranulation in ischaemia-reperfusion-induced mucosal injury in the small intestine. Ann Acad Med Singapore. 28: 79-84.
10. Buckley MG, Coleman JW (1992). Cycloheximide treatment of mouse mast cells inhibits serotonin release. Biochem Pharmacol. 44: 659-664.
11. Bueno L, Fioramonti J (1999). Effects of inflammatory mediators on gut sensitivity. Can J Gastroenterol. 13: 42A-46A.
12. Cho CH (1994). The role of endogenous ulcerogenic mediators in the pathogenesis of peptic ulcer. Life Sci. 55: 1521-1535.
13. Cho CH (2001). Current roles of nitric oxide in gastrointestinal disorders. J Phisiol Paris. 95: 253-256.
14. Cho CH, Ogle CW (1992). The pharmacological differences and similarities between stress- and ethanol-induced gastric mucosal damage. Life Sci. 51: 1833-1842.
15. Chock SP, Schmauder-Chock EA (1988). Synthesis of prostaglandins and eicosanoids by the mast cell secretory granule. Biochem Biophys Res Commun. 156: 1308-1315.
16. Church MK, Levi-Schaffer F (1997). The human mast cell. J Allergy Clin Immunol. 99: 155-160.
17. Coelho AM, Fioramonti J, Bueno L (1998). Mast cell degranulation induces delayed rectal allodynia in rats: tole of histamine and 5-HT. Dig Dis Sci. 43: 727-737.
18. Echtenacher B, Mannel DN, Hultner L (1996). Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 381: 75-77.
19. Eliakim R, Karmeli F, Okon E, Rachmilewitz D (1992). Ketotifen effectively prevents mucosal damage in experimental colitis. Gut. 33: 1498-1503.
20. Furuta GT, Schmidt-Choudhury A, Wang MY, Wang ZS, Lu L, Furlano RI, Wershil BK (1997). Mast cell-dependent tumor necrosisfactor alpha production participates in allergic gastric inflammation in mice. Gastroenterology. 113: 1560-1569.
21. Galli SJ (2000). Mast cells and basophils. Curr Opin Hematol. 7: 32-39.
22. Galli SJ, Tsai M, Wershil BK, Tam SY, Costa JJ (1995). Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol. 107: 51-53.
23. Galli SJ, Wershil BK (1996). The two faces of the mast cell. Nature. 381: 21-22.
24. Giordano OS, Guerreiro E, Pestchanker MJ (1990). The gastric cytoprotective effect of several sesquiterpene lactones. J Nat Prod. 53: 803-809.
25. Glavin GB, Hall AM (1991). Experimental gastric ulcer: Recent data suggest potential new therapeutic strategies. Asia Pacific J Pharmacol. 6: 331-339.
26. Gordon JR, Galli SJ (1990). Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 346: 274-276.
27. Guardia T, Guzmán JA, Juárez A, Guerreiro E, Giordano OS (1995). Acción antiinflamatoria de dehidroleucodina (DhL). Acta Physiol Pharmacol Ther Latinoam. 45: 226.
28. Hogaboam CM, Bissonnette EY, Chin BC, Befus D, Wallace JL (1993). Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology. 104: 122-129.
29. Hori Y, Hoshino J, Yamazaki C, Sekiguchi T, Miyauchi S, Horie K (2001). Effects of chondroitin sulfate on colitis induced by dextran sulfate sodium in rats. Jpn J Pharmacol. 85: 155-160.
30. Jiang W, Kreis ME, Eastwood C, Kirkup AJ, Humphrey PP, Grundy D (2000). 5-HT (3) and histamine H (1) receptors mediate afferent nerve sensitivity to intestinal anaphylaxis in rats. Gastroenterology. 119: 1267-1275.
31. Juárez AD, Guardia T, Guzmán JA, Giordano OS, Guerreiro E (1996). Antiinflammatory activity of dehydroleucodine (DhL) in rats. Acta Physiol Pharmacol Ther Latinoam. 46: 194.
32. Kalia N, Bardhan KD, Reed MW, Jacob S, Brown NJ (2000). Mast cell stabilization prevents ethanol-induced rat gastric mucosal injury: mechanisms of protection. J Gastroenterol Hepatol. 15: 133-141.
33. Karmeli F, Eliakim R, Okon E, Rachmilewitz D (1991). Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology. 100: 1206-1216.
34. Kiraly A, Suto G, Tam B, Hermann V, Mozsik G (2000). Vagus-mediated activation of mucosal mast cells in the stomach: effect of ketonfen on gastric mucosal lesion formation and acid secretion induced by a high dose of intracisternal TRH analogue. J Physiol Paris. 94: 131-134.
35. Kolaczkowska E, Seljelid R, Plytycz B (2001). Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J Leukoc Biol. 69: 33-42.
36. Kops SK, Theoharides TC, Cronin CT, Kashagian MG, Askenase PW (1990). Ultraestructural characteristics of ratperitoneal mast cells undergoing differential release of serotonin without histamine and without degranulation. Cell Tissue Res 262: 415-420.
37. Lawson D, Raff MC, Gomperts B, Fewtrell C, Gilula NB (1977). Molecular events during membrane fusion. A study of exocytosis in rat peritoneal mast cells. J Cell Biol. 72: 242-259.
38. Low J, Grabow D, Sommers C, Wallace J, Lesch M, Finkel M, Schrier D, Metz A, Conroy MC (1995). Cytoprotective effects of CI-959 in the rat gastric mucosa. Modulation of leukocyte adhesion. Gastroenterology. 109: 1224-1233.
39. Maria AO, Wendel GW, Guzmán JA, Giordano OS, Guerreiro E (1998). Gastric cytoprotective activity of dehydroleucodine in rats. Role of nitric oxide. Pharmacol Res. 37: 281-284.
40. Massey WA, Guo CB, Dvorak AM, Hubbard WC, Bhagavan BS, Cohan VL, Warner JA, Kagey-Sobotka A, Lichtenstein LM (1991). Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. J Immunol. 147: 1621-1627.
41. Mc Neil HP, Austen KF (1995). Biology of the mast cell. In: Samter's Immunologic Diseases. MM Frank, KF Austen, HN Claman, ER Unanue ER, Eds. Little, Brown and Company., New York, pp. 185-204.
42. Mekori YA, Metcalfe DD (2000). Mast cells in innate immunity. Immunol Rev. 173: 131-140.
43. Middleton E, Kandaswami C, Theoharides TC (2000). The Effects of Plant Flavonoids on Mammalian Cells: Implications for Inflammation, Heart Disease, and Cancer. Pharmacol Rev. 52: 673-751.
44. Myers CP, Hogan D, Yao B, Koss M, Isenberg JI, Barrett KE (1998). Inhibition of rabbit duodenal bicarbonate secretion by ulcerogenic agents: histamine-dependent and independent effects. Gastroenterology. 114: 527-535.
45. Ohta Y, Kobayashi T, Nishida K, Ishiguro I (1997). Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions in gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator. Dig Dis Sci. 42: 1221-1232.
46. Penissi AB, de Rosas JC, Fogal T, Mariani ML, Nicovani S, Rudolph MI, Piezzi RS (2002). Dehidroleucodina inhibe la degranulación de mastocitos peritoneales inducida por el compuesto 48/80. Medicina. 62: 513.
47. Penissi AB, Fogal T, Guzmán JA, Piezzi RS (1998). Gastroduodenal mucosal protection induced by dehydroleucodine. Mucus secretion and role of monoamines. Dig Dis Sci. 43: 791-798.
48. Penissi AB, Mariani ML, Souto M, Guzmán JA, Piezzi RS (2000). Changes in gastroduodenal 5-hydroxytryptamine-containing cells induced by dehydroleucodine. Cells Tissues Organs. 166: 259-266.
49. Penissi AB, Piezzi RS (1999). Effect of dehydroleucodine on mucus production. A quantitative study. Dig Dis Sci. 44: 708-712.
50. Penissi AB, Rudolph MI, Fogal T, Piezzi RS (2003a). Changes in duodenal mast cells in response to dehydroleucodine. Cells Tissues Organs. 173: 234-241.
51. Penissi AB, Rudolph MI, Villar M, Coll RC, Fogal TH, Piezzi RS (2003b). Effect of dehydroleucodine on histamine and serotonin release from mast cells in the isolated mouse jejunum. Inflamm Res. 52: 199-205.
52. Piezzi RS, Guzmán JA, Guardia T, Pestchanker MJ, Guerreiro E, Giordano OS (1995). Dehydroleucodine prevents ethanol-induced necrosis in the mice duodenal mucosa. A histological study. Biocell 19: 27-33.
53. Raud J (1990). Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent in flammation. Br J Pharmacol, 99: 449-54.
54. Ro JY, Lee BC, Kim JY, Chung JY, Chung MH, Lee SK, Jo TH, Kim KH, Park YI (2000). Inhibitory mechanism of Aloe single component (alprogen) on mediator release in guinea pig lung mast cells activated with specific antigen-antibody reactions. JPET. 292: 114-121.
55. Robert A (1976). Antisecretory antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prost Thrombox Res. 2: 507-20.
56. Ruh J, Vogel F, Schmidt E (2000). In vivo assessment of villous microcirculation in the rat small intestine in indomethacin-induced inflammation: role of mast-cell stabilizer ketotifen. Acta Physiol Scand. 170: 137-143.
57. Saavedra-Delgado AM, Turpin S, Metcalfe DD (1984). Typical and atypical mast cells of the rat gastrointestinal system: distribution and correlation with tissue histamine. Agents Actions. 14: 1-7.
58. Schwartz LB (1998). The Mast Cell. In: Textbook of Rheumatology. W.N. Kelley, E.D. Harris, S. Ruddy and C.B. Sledge, Eds. W.B. Saunders Company, Philadelphia, pp. 161-175.
59. Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM (1987). Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 138: 2611-2615.
60. Stenton GR, Vliagoftis H, Befus D (1998). Role of intestinal mast cells in modulating gastrointestinal pathophysiology. Ann Allergy Asthma Immunol. 81: 1-15.
61. Tanaka A, Mizoguchi H, Kunikata T, Miyazawa T, Takeuchi K (2001). Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats. J Physiol Paris. 95: 35-41.
62. Theoharides TC, Kops SK, Bondy PK, Askenase PW (1985). Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem Pharmacol. 34: 1389-1398.
63. Theoharides TC, Letourneau R, Patra P, Hesse L, Pang X, Boucher W, Mompoint C, Harrington B (1999). Stress-induced rat intestinal mast cell intragranular activation and inhibitory effect of sulfated proteoglycans. Dig Dis Sci. 44: 87S-93S.
64. Valent P, Sillaber C, Bettelheim P (1991). The growth and differentiation of mast cells. Prog Growth Factor Res. 3: 27-41.
65. Vliagoftis H, Worobec AS, Metcalfe DD (1997). The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol. 100: 435-440.
66. Wallace JL (1996). Cooperative modulation of gastrointestinal mucosal defence by prostaglandins and nitric oxide. Clin Invest Med. 19: 346-51.
67. Wallace JL (2001). Mechanisms of protection and healing: current knowledge and future research. Am J Med. 110: S19-S23.
68. Wallace JL, Granger DN (1996). The cellular and molecular basis of gastric mucosal defense. FASEB J. 10: 731-2740.
69. Wallace JL, Ma L (2001). Inflammatory Mediators in Gastrointestinal Defense and Injury. Exp Biol Med. 226: 1003-1015.
70. Wershil BK (2000). Mast cell-deficient mice and intestinal biology. Am J Physiol Gastrointest Liver Physiol. 278: G343-G348.
71. Wershil BK, Galli SJ (1991). Gastrointestinal mast cells. New approaches for analyzing their function in vivo. Gastroenterology Clinics of North America. 20: 613-627.
72. Whittle B (1993). Modulation by prostanoids of the release of inflammatory mediators from mast cells: involvement in mucosal protection? Gastroenterology. 104: 314-317.